<DOC>
	<DOCNO>NCT00186290</DOCNO>
	<brief_summary>To evaluate role ablative allogeneic hematopoietic cell transplantation treatment advance leukemia lymphoma .</brief_summary>
	<brief_title>Allo BMT Advanced Leukemia High Grade Lymphoma</brief_title>
	<detailed_description>To determine disease free survival overall survival patient ALL ANLL induction failure , relapse , subsequent remission CML several phase recurrent lymphoblastic lymphoma receive fractionate TBI , etoposide cyclophosphamide follow allogenic bone marrow graft histocompatible sibling donor . Fractionated Total Body Irradiation ( FTBI ) , Etoposide ( VP-16 ) Cyclophosphamide ( CY ) Followed Allogeneic Bone Marrow Transplantation Patients Advanced Leukemia High Grade Lymphoma</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>HLA identical donor adequate organ function life threaten disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>